"There`s definitely a growing demand for this form of solution," Nissim explains. "To some companies, especially those facing venture capital deadlines and clinical trial windows, choosing an integrated connector system can offer a point of freedom that could think the conflict between success and failure. Similarly, from a patient`s perspective, it might be one of the factors that determine whether or not a breakthrough therapy ever makes it to market.
According to Nissim, these are about of the same drivers behind his company`s decision to get the new SYGNUS system. He says the system, which combines electrical contacts and silicone isolation seals in a pre-tested, configurable stack, helps manufacturers eliminate dual sourcing issues and integrate proven technology in a "plug-and-play unit that can significantly accelerate IPG development." Like most of Bal Seal`s electrical conducting solutions, SYGNUS employs unique Canted-coil™ spring technology to control multi-point contact. The springs also provide very low insertion force and their individual coils and right for bothmisalignment and surface irregularities, making them extremely reliable, low-resistance contact components, Nissim says. For more data about Bal Seal`s presentation and the balance of MD&M`s "Innovation Briefs" series, visit http://www.canontradeshows.com/expo/univ/Minn10/ibt.html. To take more about Bal Seal`s SYGNUS Implantable Contact System, visit the party at booth #344 during MD&M Minneapolis, October 13-14th, 2010 at the Minneapolis Convention Center Or, click www.sygnusconnects.com. About Bal Seal Engineering, Inc. Bal Seal Engineering, Inc. is a worldwide supplier of custom-engineered sealing, connecting, conducting and shielding solutions for industry worldwide. The company`s products employ unique Canted-coil™ spring technology for enhanced performance and reliability. For the latest news and data about Bal Seal, visit http://mediaroom.balseal.com or call 800.366.1006. Full ArticleFor a Perfect Edition of this BUSINESS WIRE Press Release
No comments:
Post a Comment